{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:58Z","timestamp":1794047518076,"version":"4.8.0"},"reference-count":3,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2025.289053","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:20:39Z","timestamp":1757578839000},"page":"1507-1508","source":"Crossref","is-referenced-by-count":0,"title":["Response to Comment on: \u201cHepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies\u201d"],"prefix":"10.3324","volume":"111","author":[{"given":"Matthew J.","family":"Rees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"88388","doi-asserted-by":"crossref","unstructured":"Rees MJ, Quach H, Jardine D, Thompson A. Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies. Haematologica. 2025; 110(12):3168-3170.","DOI":"10.3324\/haematol.2025.288359"},{"key":"88389","doi-asserted-by":"crossref","unstructured":"Rago A, Ridola L, Caravita di Toritto T. HBV infection in the era of T-cell engagers in multiple myeloma: unresolved challenges and unmet needs. Comment on: Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies. Haematologica. 2026; 111(4):1503-1504.","DOI":"10.3324\/haematol.2025.288942"},{"key":"88390","doi-asserted-by":"crossref","unstructured":"Cornberg M, Sandmann L, Jaroszewicz J. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2025; 83(2):502-583.","DOI":"10.1016\/j.jhep.2025.03.018"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12278\/78809","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12278\/79895","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12278\/78809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:09:45Z","timestamp":1794046185000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":3,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2025.289053","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}